ERX-41 shows activity in rare aggressive Breast Cancer subtype

San Antonio, TX - March 23, 2026.We are pleased to present our new open-access paper in Biomolecules (link here).Our paper shows activity of ERX-41 in Inflammatory breast cancer (IBC), a rare (2–4%) extremely aggressive subset of breast…

Optimization of LIPA targeting in Ovarian Cancer

San Antonio TX, February 06, 2026Introducing ERX-208 - our supercharged ERX-41 analog for ovarian cancer!Publication in Oncogene shows the same powerful MOA of inducing uncompensated ER stress, but ERX-208 delivers dramatically higher…